title: Re: Wayne J.G. Hellstrom, Marc Gittelman, Jonathan Jarow, et al. an evaluation of semen characteristics in men 45 years of age or older after daily dosing with tadalafil 20 mg: results of a multicenter, randomized, double-blind, placebo-controlled, 9-month study. Eur Urol 2008;53:1058-65.
authors: Giorgio
authors: G
authors: Pomara
authors: Domenico
authors: D
authors: Canale
authors: Paolo
authors: P
authors: Turchi
authors: Francesco
authors: F
authors: Francesca
mesh_terms: D002243:Carbolines / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D007172:Erectile Dysfunction / Q000188:drug therapy* / Q000503:physiopathology; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D010726:Phosphodiesterase Inhibitors / Q000008:administration & dosage*; D016032:Randomized Controlled Trials as Topic; D012661:Semen / Q000166:cytology* / Q000187:drug effects / Q000502:physiology; D013091:Spermatogenesis / Q000187:drug effects / Q000502:physiology*; D000068581:Tadalafil; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D002243:Carbolines; D010726:Phosphodiesterase Inhibitors; D000068581:Tadalafil